Introduction
============

Colistin has been the only hope so far for the treatment in worst scenarios of antibiotic-resistant bacterial infections, including carbapenem-resistant Enterobacteriaceae. Recent reports indicate a colistin resistance in multidrug-resistant (MDR) *Klebsiella pneumoniae* to approximately 45%.[@b1-idr-11-1183] The main mechanism attributed to colistin resistance is the upregulation of PhoQ/PhoP, a two-component system (TCS), which in turn activates the pmrHFIJKLM operon. Mutations in PhoQ/PhoP as well as CrrAB signaling system are found to exert resistance against colistin.[@b2-idr-11-1183] A significant molecular mechanism that has recently been described in colistin resistance in *K pneumoniae* is the mutation/inactivation of mgrB gene encoding for a 47--amino acid transmembrane protein that exerts a negativefeedback effect on PhoQ/PhoP. An inactivation of this gene is reported to upregulate the PhoQ/PhoP TCS, thus conferring resistance against colistin.[@b3-idr-11-1183] A plasmid-mediated mobile colistin resistance gene (*mcr*-1,-2, and -3 variants) has recently been reported from several parts of the globe indicating increased horizontal transfer of this resistance.[@b4-idr-11-1183]

Materials and methods
=====================

Twenty-three nonrepetitive, confirmed, multidrug, colistin-resistant (ColR) *K. pneumoniae* isolates were studied. These isolates were collected, screened, and stored in the microbiology lab during 2011--2015. Single colonies were picked up and grown in liquid Tryptic Soy Broth (TSB) medium at 37°C overnight. Minimum inhibitory concentrations (MICs) of antibiotics for these isolates were determined using Micro Vitek 2 (bioMerieux, Durham, NC, USA). MIC breakpoints for carbapenemase were defined according to the modified 2010 CLSI guidelines.[@b5-idr-11-1183] ColR *K. pneumoniae* isolates were further subjected to analysis for *mgrB, PhoP/PhoQ, pmrA/B*, and *CrrAB* genes. Polymerase chain reaction (PCR) amplification of plasmid-borne mobile colistin resistance (*mcr*) genes was carried out using the primers described by Liu et a1.[@b6-idr-11-1183] Resistance genes and the genes for multilocus sequence typing, virulence factors, *mgr*B, *PhoP/Q*, *PmrA/B*, and *CrrB* were amplified using their specific primers, reported earlier.[@b7-idr-11-1183]--[@b10-idr-11-1183] The amplicon of these PCR reactions was sequenced on an ABI 3100 DNA analyzer (Life Technologies, USA). The sequences were analyzed using SeqMan software (Lasergene, DNAstar) and blasted against the GenBank (NCBI, USA) sequence database. The type of insertion elements (IS) present in *mgrB* gene was determined by IS Finder.[@b11-idr-11-1183] The evolutionary histories were inferred using the neighbor-joining method. The evolutionary distances were computed using the maximum composite likelihood method, for ISKpn14 and IS903 nucleotide sequences separately. Evolutionary analyses were conducted using Mega6 software.[@b12-idr-11-1183]

Ethics approval
---------------

The *K. pneumoniae* isolates studied in this report are part of the collection of pathogens in the Microbiology Laboratory of our hospital collected as routine hospital procedure. Hence, no ethical clearance/patient consent was needed.

Results
=======

Here we present our observations on the 23 ColR *K. pneumoniae* isolates from Saudi Arabia; probably the first report on the mutations in *mgr*B and other regulatory systems involved in colistin resistance.

Demography, MIC, sequence typing, and carbapenem resistance genes
-----------------------------------------------------------------

The isolates were collected from different sources including blood, wound, tracheal aspirate, urine, and so on from the patients admitted to different wards of King Abdul-Aziz Medical City, National Guards Hospital Riyadh. All isolates belonged to MDR group of *K. pneumoniae* (resistant to more than four groups of antibiotics, including carbapenem). OXA-48 and/or NDM-1 genes were the major carbapenemase determinants. None of the isolates was positive for KPC, VIM, or IMP gene. The distribution of resistance genes, virulence factors, and sequence types (STs) among isolates is given in [Table 1](#t1-idr-11-1183){ref-type="table"}.

mgrB and other components of colistin resistance mechanism
----------------------------------------------------------

We were unable to detect the plasmid-borne mobile ColR genes mcr-1, -2, or -3 in any of our isolates. Of the 23 resistant isolates, 18 had mutations in their *mgr*B gene. Seventeen isolates carried IS elements while one had a nucleotide deletion in the open reading frame (ORF) of *mgr*B gene. Three types of elements belonging to three different families of IS were encountered in either ORF or the promoter of *mgr*B gene. Ten isolates were carrying ISKpn14, four isolates had ISKpn28, and three had IS903 in their *mgr*B gene. Out of 10 isolates with ISKpn14 insertion, four had it at position +52 of *mgr*B gene, two at +22, and two at −12 (in promoter region, upstream of start codon). All isolates carrying ISKpn28 belonged to ST-14. Three isolates with IS903 element, all belonging to ST-152, had it at +70 of the *mgr*B gene ([Figure 1A](#f1-idr-11-1183){ref-type="fig"}). Insert sequences were clearly marked for their left and right inverted repeats (IRs). The IR sequences were as follows: ISKpn14 IRL: CCAACTTA, IRR: TAAGTTGG; for ISKpn 903 IRL: GCTTTGTTG, IRR: CAACAAAGC and for ISKpn28 IRL: ATATTGCAATT, IRR: AATTGCAATAT. The mgrB sequences with these insertions are deposited in the GenBank with accession numbers MG930931, MG930932, MG930933, MG930934, MG930935, MG930936, and MG930937. One isolate had a deletion of one nucleotide ("T") at position +22 of the *mgr*B gene sequence, resulting in a premature stop codon at position 9 of the *mgr*B protein. Five isolates had L26Q mutation, whereas one isolate had an additional mutation S72L in the *PhoP* gene of TCS. No mutations were found in other compartments such as PhoQ, PmrA/B, and CrrAB of the signaling system.

Discussion
==========

This is probably the first report from Saudi Arabia describing the molecular mechanisms for colistin resistance in *K. pneumoniae*. Although certain mutations appear to be clone-specific; a broad polyclonal involvement of colistin resistance was observed in our isolates. All our 23 ColR *K. pneumoniae* isolates are negative for plasmid-borne *mcr* gene underscoring the involvement of chromosomal-mediated resistance. This is in line with the observations made recently by Sonnevend et al.[@b13-idr-11-1183] It has been observed that greater colistin resistance resulted in *K. pneumoniae* by the mutation/inactivation of *mgrB* than the mutations in the genes of the TCSs (pmrA/pmrB or PhoP/PhoQ).[@b3-idr-11-1183],[@b14-idr-11-1183] We also encountered a similar situation, and 88% of our ColR isolates showed mutations in their mgrB gene alone.

Although IS5-like insertion element has been reported to be the main element for the *mgr*B disruption in *K. pneumoniae*, insertion of ISKpn14 (a member of IS1 family) is also sporadically reported.[@b8-idr-11-1183],[@b15-idr-11-1183] However, we found ISKpn14 to be the major IS and 59% of our isolates have ISKpn14- mediated *mgr*B gene disruption. The high incidence of ISKpn14 positivity in our isolates is not a mere expansion of a single clone because these isolates belonged to at least five different STs. The orientation and site of insertion are also varying ([Figure 1A](#f1-idr-11-1183){ref-type="fig"}). Though ISKpn14 is inserted at as many as six locations in the *mgr*B gene, site +52 appears to have a recombination event. Four isolates from two different STs had this IS element in both orientations. As our isolates carrying ISKpn14 ranged from year 2012 to 2015, there are variations in the IS sequences. A phylogenetic tree ([Figure 1C](#f1-idr-11-1183){ref-type="fig"}) comparing the ISKpn14 sequences from these isolates segregated the older clones from the recent ones indicating their divergence through single-nucleotide polymorphisms.

The novel finding of this study is the incidence of 1100 bp ISKpn28 (a member of IS481 family) in four isolates. To the best of our knowledge, this is the first report on ISKpn28 involvement in *mgr*B disruption in *K. pneumoniae* from any part of the globe. Interestingly, all isolates shared 100% similarities in their ISKpn28 sequence and all had the same integration site (+91) in the *mgr*B gene and could be the result of clonal expansion of a single isolate with this mutation. According to our records, ST-14 started circulating in our hospital only from mid-2014 and the isolates carrying ISKpn28 in this study are from year 2015, indicating the insertion to be a recent event. ST-14 with *mgrB* mutations has recently been reported from several parts of the world and appears to have become an endemic ColR clone.[@b14-idr-11-1183]

Another significant finding of this study is the presence of IS903 at +70 of *mgr*B, in three *K. pneumoniae* isolates belonging to ST-152, a clone found to be typically an NDM-1 gene carrier in our carbapenem-resistant (CR) *K. pneumoniae* isolates (data not shown). IS903, a member of IS5 family, is implicated in antibiotic resistance, either as a carrier of resistance gene or an element for modifying the targets of antibiotic action.[@b16-idr-11-1183] Position +70 (from start codon) of the *mgr*B gene sequence appears to be a hotspot for insertion of IS903. GenBank DNA sequence depositions from different countries including China, Greece, and France reported the same +70 position, as the site of integration, for IS903 into the *mgr*B gene of their isolates.[@b3-idr-11-1183],[@b16-idr-11-1183] It suggests that there had been a recombination event at this location in the chromosome of the bacteria. We have previously reported a disruption of *omp-36* gene in four CR *K. pneumoniae* isolates from ST-29 because of IS903 insertion of similar size and the same IR sequences as found in our present ColR isolates, in carbapenem-resistant but colistin-susceptible *K. pneumoniae* isolates from year 2010.[@b9-idr-11-1183] However, one of the three isolates with IS903-mediated *mgr*B disruption also showed an insertion of IS903 in its *omp-36* gene indicating its potential role not only in colistin resistance but also for carbapenem. A similar mechanism for tigecycline resistance in *K. pneumoniae* has been reported, where IS5 is integrated into the promoter region of a putative efflux pump operon called kpgABC.[@b17-idr-11-1183] More studies are needed to evaluate the spacers that possibly induce the mobilization of these elements from plasmids to the chromosome to transform the MDR pathogen into a pan-drug-resistant one.[@b18-idr-11-1183] The phylogenetic analysis comparing the IS903 sequences from *omp-36* and *mgr*B in our isolates as well as the GenBank-deposited IS5 insert sequences for *mgr*B disruption from other countries showed a largely congruent distribution of the isolates ([Figure 1B](#f1-idr-11-1183){ref-type="fig"}).

Deletions of single nucleotide causing a frame shift resulting in premature stop codon are widely reported in colistin resistance in *K. pneumoniae* and other bacteria.[@b3-idr-11-1183],[@b8-idr-11-1183],[@b15-idr-11-1183] We found that one isolate belonging to ST-22 carried a deletion of a nucleotide ("T" at +22) in *mgr*B ORF causing a frame shift and premature stop codon and resulting in a shortened nonfunctional protein of only nine amino acids.

Several nonsynonymous mutations including one at L26Q in *PhoP* gene have been reported to cause colistin resistance;[@b3-idr-11-1183] five of our isolates had L26Q mutation in *PhoP* gene. Due to the abundance of studies reporting the involvement of IS elements in disruption of *mgrB* as well as PhoP mutations in colistin resistance, we assume that both the insertional inactivation of *mgr*B and the L26Q mutation in PhoP are the cause for colistin resistance in these isolates. It is interesting to note that in all our isolates from year 2011 till mid-2012, L26Q mutation was the only probable mechanism of colistin resistance and the isolates showed no insertional element in their mgrB gene. *Mgr*B disruption through ISs is a later phenomenon than the *PhoP* mutations. These data, though on a small number of isolates, support the notion that under stressful situations such as antibiotic exposure, the bacteria require a more robust structural change in the genome to bring crucial beneficial variations, and this change is impossible through simple point mutations; ISs do this job more efficiently.[@b19-idr-11-1183],[@b20-idr-11-1183] In conclusion, our report depicts the increased role of IS elements in colistin resistance in *K. pneumoniae* through *mgr*B disruption. Also, the abundance of insertion sites (as many as nine places) in *mgr*B indicates the plasticity of this gene.
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![(**A**) mgrB gene sequence with the three ISs inserted at different positions in the open reading frame and the promoter region of the gene. The bold-face TTTTGA and TAAACT are −35 and −10 boxes of the promoter, whereas GTG and TAA are start and stop codons, respectively. The arrows and the numbers at their base indicate the orientation and the upstream (−) and downstream (+) positions of IS from the start codon. The numbers in parentheses indicate the multiples of isolates with the particular sequence type; (**B**) Phylogenetic relationship based on comparisons of IS903 insert sequence in *omp-36* gene of our 2010 outbreak isolates in and the mgrB gene of the present study population and six other GenBank depositions; (**C**) Phylogenetic relationship based on ISKpn14 sequence among isolates of this study carrying the insert. The bar in (**B**) and (**C**) is the divergence scale denoting number of substitutions per site.\
**Abbreviations:** IS, insertion element; KP, *Klebsiella pneumoniae;* ST, sequence type.](idr-11-1183Fig1){#f1-idr-11-1183}

###### 

Showing the details of demography, MICs, virulence factors, and determinants of carbapenem resistance

  Isolate \#   ST    Index date   Sample source     IS element in *mgrB*   mgrB/PhoP point mutations   Virulence factors           Colist   Imipen   Merop   Carbapenemase
  ------------ ----- ------------ ----------------- ---------------------- --------------------------- --------------------------- -------- -------- ------- ---------------
  52           974   22-Oct-11    Wound             No insert              PhoP/L26Q                   mrkD, entB                  R        R        R       OXA-48
  54           37    5-Sep-11     Abdominal drain   No insert              PhoP/L26Q                   mrkD, entB                  R        32R      32R     OXA-48
  62           709   1-Sep-11     Blood             No insert              PhoP/L26Q                   iut, kfu, entB              R        4R       4R      OXA-48
  67           348   2-Jul-11     Rectal            No insert              PhoP/L26Q                   mrkD, entB                  R        R        8R      OXA-48
  90           37    5-Jun-12     Blood             No insert              PhoP/L26Q                   mrkD, entB                  R        R        R       OXA-48
  114          16    18-Nov-12    Trachea           ISKpn14                No mutation                 ybtS, mrkD, entB            R        8R       16R     OXA-48
  120          48    3-Nov-12     Rectal            ISKpn14                No mutation                 ybtS, mrkD, entB            R        NA       16R     OXA-48
  124          152   17-Sep-12    Urine             IS903                  No mutation                 ybtS, mrkD, entB            R        4R       4R      OXA-48, NDM-1
  154          152   31-Jan-13    Trachea           IS903                  No mutation                 ybtS, mrkD, entB            R        4R       4R      OXA-48, NDM-1
  166          15    13-Jul-13    Wound             ISKpn14                PhoP/L26Q                   ybtS, mrkD, entB, kfu       R        16R      16R     OXA-48
  178          15    22-Nov-13    Other             ISKpn14                No mutation                 ybtS, mrkD, entB, kfu       R        8R       16R     OXA-48
  197          14    15-May-14    Urine             ISKpn14                No mutation                 ybtS, mrkD, ent**B**        R        4R       4R      ND
  218          101   20-Oct-14    Urine             ISKpn14                No mutation                 ybtS, mrkD, entB, kfu       R        16R      16R     OXA-48, NDM-1
  236          22    23-Jan-15    Wound             No insert              mgrB/▲t\@22                 mrkD, entB                  R        16R      16R     OXA-48
  261          14    15-May-15    Urine             ISKpn28                No mutation                 ybtS, mrkD, entB, K2, kfu   R        16R      16R     OXA-48, NDM-1
  278          307   3-Jul-15     Blood             ISKpn14                No mutation                 mrkD, entB                  R        21       21      OXA-48
  287          101   21-Jul-15    Trachea           ISKpn14                No mutation                 ybtS, mrkD, entB, kfu       R        16R      16R     OXA-48
  300          152   25-Oct-15    Blood             IS903                  No mutation                 ybtS, mrkD, entB            R        11       4R      ND
  303          101   3-Nov-15     Urine             ISKpn14                No mutation                 ybtS, mrkD, entB, kfu       R        16R      16R     OXA-48, NDM-1
  305          14    27-Oct-15    Trachea           ISKpn28                No mutation                 ybtS, mrkD, entB            R        16R      16R     NDM-1
  309          14    8-Nov-15     Blood             ISKpn28                No mutation                 ybtS, mrkD, entB, K2, kfu   R        16R      16R     NDM-1
  313          14    30-Nov-15    Blood             ISKpn28                No mutation                 ybtS, mrkD, entB            R        16R      16R     NDM-1
  318          14    7-Dec-15     Urine             ISKpn14                No mutation                 ybtS, mrkD, entB, K2, kfu   R        21       16R     OXA-48

**Abbreviations:** IS, insertion element; MICs, minimum inhibitory concentrations; NA, not available; ND, not detected; ST, sequence type; R, resistant; I, intermediate.
